Investor Presentaiton
4DMedical™
Commercialisation: Two Pillars
Clinical trials
3!!
Research partners delivering the body of
scientific evidence for clinical use
Commercial pilots
Physicians gaining familiarity with technology and
business case for clinical adoption
Who
Why
.
Eminent researchers and
•
leading medical
institutes
Diagnostics, treatment
efficacy, monitoring,
disease progression and
more
Who
•
Respiratory specialists,
imaging centres, hospitals
Why
•
•
Assess holistic regional lung
function for patient management
- ventilation and perfusion
Alternative to nuclear medicine
Outcome:
Scientific investigation into case applications
Publishing manuscripts and presenting research to industry
Study design: Full scientific method per researcher
Outcome:
⚫Clinical familiarisation
• Clinical and business case for technology adoption
Pilot design: Tiered per facility & physician interest
4DMedical Limited (ASX:4DX) Investor Presentation | September 2022
19View entire presentation